Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.88 is 21% below its 5-year average of 4.92, near the low end of its 5-year range (1.19–21.04).
As of the fiscal period ended Tuesday, June 30, 2026. 23.66% above its 12-month average of 3.14.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.88.
CURRENT RATIO
3.88
CURRENT RATIO AVG TTM
3.14
CURRENT RATIO AVG 3Y
2.57
CURRENT RATIO AVG 5Y
4.92
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+23.66%
CURRENT VS 3Y AVG
+50.81%
CURRENT VS 5Y AVG
-21.18%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.39
median of 643 covered companies
CURRENT VS SECTOR MEDIAN
+14.39%
vs the sector median at left
Acurx Pharmaceuticals, Inc.
Market Cap
$5.57M
Current Ratio
3.88
TTM Avg
3.14
3Y Avg
2.57
5Y Avg
4.92
Market Cap
$5.68M
Current Ratio
2.35
TTM Avg
1.31
3Y Avg
0.84
5Y Avg
0.78
Market Cap
$5.32M
Current Ratio
0.09
TTM Avg
0.18
3Y Avg
0.44
5Y Avg
0.97
Market Cap
$5.26M
Current Ratio
1.44
TTM Avg
1.10
3Y Avg
1.11
5Y Avg
1.95
Market Cap
$5.84M
Current Ratio
11.70
TTM Avg
17.23
3Y Avg
23.62
5Y Avg
22.05
Market Cap
$5.21M
Current Ratio
1.12
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.12
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acurx Pharmaceuticals, Inc. (ACXP) | $5.57M | 3.88 | 3.14 | 2.57 | 4.92 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.68M | 2.35 | 1.31 | 0.84 | 0.78 |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | 3.01 | 3.95 | 2.52 | 4.28 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | 0.09 | 0.18 | 0.44 | 0.97 |
| Lucyd, Inc (LUCY)vs › | $5.81M | 12.06 | 10.77 | 9.40 | 6.47 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.26M | 1.44 | 1.10 | 1.11 | 1.95 |
| enVVeno Medical Corporation (NVNO)vs › | $5.84M | 11.70 | 17.23 | 23.62 | 22.05 |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.21M | 1.12 | 0.07 | 0.07 | 0.12 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | 0.19 | 0.06 | 0.46 | 2.58 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.99M | 119.39 | 100.04 | 53.39 | 40.10 |
Current Ratio
3.88
Quick Ratio
3.88
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.88 |
| 2026-03-31 | 3.78 |
| 2025-12-31 | 3.18 |
| 2025-09-30 | 2.47 |
| 2025-06-30 | 2.38 |
| 2025-03-31 | 1.93 |
| 2024-12-31 | 1.19 |
| 2024-09-30 | 1.80 |
| 2024-06-30 | 2.09 |
| 2024-03-31 | 2.93 |
| 2023-12-31 | 2.53 |
| 2023-09-30 | 2.22 |
| 2023-06-30 | 3.06 |
| 2023-03-31 | 3.56 |
| 2022-12-31 | 4.55 |
| 2022-09-30 | 9.26 |
| 2022-06-30 | 19.43 |
| 2022-03-31 | 17.89 |
| 2021-12-31 | 15.71 |
| 2021-09-30 | 21.04 |
| 2021-06-30 | 9.09 |
| 2021-03-31 | 5.73 |
| 2020-12-31 | 6.82 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
